Recent ABOS News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:42:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:48:08 AM
- Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 08/13/2024 11:00:00 AM
- Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 08:00:00 PM
- Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer’s Disease • GlobeNewswire Inc. • 07/29/2024 11:00:00 AM
- Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024 • GlobeNewswire Inc. • 07/28/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:54:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:51:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:49:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:46:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:41:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:36:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:47:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:35:38 AM
- Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/13/2024 08:00:00 PM
- Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference • GlobeNewswire Inc. • 05/08/2024 09:47:25 PM
- Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease • GlobeNewswire Inc. • 05/08/2024 12:00:00 PM
- Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 08:00:00 PM
- Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease • GlobeNewswire Inc. • 04/04/2024 12:00:00 PM
- Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights • GlobeNewswire Inc. • 03/26/2024 11:00:00 AM
- Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024 • GlobeNewswire Inc. • 03/19/2024 08:00:00 PM
- Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days • GlobeNewswire Inc. • 03/12/2024 08:00:00 PM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM